| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | chromatin organization | FAM47A UIMC1 VRK1 ZMYND11 ARID4B PHF20 KDM5A KDM3B CHD9 TDG REST NSD3 YEATS4 SUDS3 CFDP1 MPHOSPH8 RERE HDAC1 | 2.76e-05 | 896 | 137 | 18 | GO:0006325 |
| GeneOntologyBiologicalProcess | chromatin remodeling | FAM47A UIMC1 VRK1 ARID4B KDM5A KDM3B CHD9 TDG REST NSD3 YEATS4 SUDS3 CFDP1 MPHOSPH8 RERE HDAC1 | 3.39e-05 | 741 | 137 | 16 | GO:0006338 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | FAM47A UIMC1 VRK1 ZMYND11 ARID4B PHF20 KDM5A DLGAP5 KDM3B CHD9 TDG REST NSD3 YEATS4 SUDS3 CFDP1 MPHOSPH8 RERE HDAC1 | 3.43e-05 | 999 | 137 | 19 | GO:0071824 |
| GeneOntologyCellularComponent | nuclear body | RNF32 UIMC1 VRK1 SETX RBBP6 PARP3 SRSF11 TDG PNISR NOP58 NAMPT CDC40 CCNB3 SUDS3 DNAJC11 TENM1 RERE SF3B2 SON | 5.63e-06 | 903 | 135 | 19 | GO:0016604 |
| GeneOntologyCellularComponent | histone deacetylase complex | 1.87e-05 | 85 | 135 | 6 | GO:0000118 | |
| GeneOntologyCellularComponent | muscle myosin complex | 1.39e-04 | 16 | 135 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | Sin3-type complex | 3.71e-04 | 22 | 135 | 3 | GO:0070822 | |
| GeneOntologyCellularComponent | nuclear speck | RBBP6 SRSF11 PNISR NAMPT CDC40 CCNB3 DNAJC11 TENM1 SF3B2 SON | 4.98e-04 | 431 | 135 | 10 | GO:0016607 |
| GeneOntologyCellularComponent | myosin filament | 5.46e-04 | 25 | 135 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 7.67e-04 | 28 | 135 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | pre-snoRNP complex | 8.51e-04 | 7 | 135 | 2 | GO:0070761 | |
| GeneOntologyCellularComponent | sarcomere | 1.19e-03 | 249 | 135 | 7 | GO:0030017 | |
| GeneOntologyCellularComponent | nuclear chromosome | 1.33e-03 | 254 | 135 | 7 | GO:0000228 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | UIMC1 MIS18BP1 ARID4B PHF20 CHMP1B SYNE1 KDM3B MCM3 UPF3A POM121C POLR3A CDC40 SUDS3 CFDP1 CHMP3 C1D RERE SF3B2 HDAC1 | 1.38e-03 | 1377 | 135 | 19 | GO:0140513 |
| GeneOntologyCellularComponent | junctional membrane complex | 1.45e-03 | 9 | 135 | 2 | GO:0030314 | |
| Domain | Transl_init_fac_IF2/IF5 | 5.19e-05 | 2 | 135 | 2 | IPR002735 | |
| Domain | Fam133 | 5.19e-05 | 2 | 135 | 2 | IPR026766 | |
| Domain | eIF2B_5 | 5.19e-05 | 2 | 135 | 2 | SM00653 | |
| Domain | Transl_init_fac_IF2/IF5_Zn-bd | 5.19e-05 | 2 | 135 | 2 | IPR016190 | |
| Domain | Transl_init_fac_IF2/IF5_N | 5.19e-05 | 2 | 135 | 2 | IPR016189 | |
| Domain | eIF-5_eIF-2B | 5.19e-05 | 2 | 135 | 2 | PF01873 | |
| Domain | - | 5.19e-05 | 2 | 135 | 2 | 3.30.30.50 | |
| Domain | I-BAR_dom | 1.00e-04 | 13 | 135 | 3 | IPR013606 | |
| Domain | Zinc_finger_PHD-type_CS | 1.07e-04 | 65 | 135 | 5 | IPR019786 | |
| Domain | Myosin_N | 1.58e-04 | 15 | 135 | 3 | PF02736 | |
| Domain | Myosin_N | 1.58e-04 | 15 | 135 | 3 | IPR004009 | |
| Domain | PHD | 2.11e-04 | 75 | 135 | 5 | PF00628 | |
| Domain | Znf_PHD-finger | 2.69e-04 | 79 | 135 | 5 | IPR019787 | |
| Domain | Myosin_tail_1 | 2.78e-04 | 18 | 135 | 3 | PF01576 | |
| Domain | Myosin_tail | 2.78e-04 | 18 | 135 | 3 | IPR002928 | |
| Domain | IQ | 3.02e-04 | 81 | 135 | 5 | SM00015 | |
| Domain | - | 3.08e-04 | 4 | 135 | 2 | 1.20.5.520 | |
| Domain | Myosin-like_IQ_dom | 3.29e-04 | 19 | 135 | 3 | IPR027401 | |
| Domain | - | 3.29e-04 | 19 | 135 | 3 | 4.10.270.10 | |
| Domain | PHD | 4.68e-04 | 89 | 135 | 5 | SM00249 | |
| Domain | IQ_motif_EF-hand-BS | 4.92e-04 | 90 | 135 | 5 | IPR000048 | |
| Domain | THYMOSIN_B4 | 5.11e-04 | 5 | 135 | 2 | PS00500 | |
| Domain | Thymosin | 5.11e-04 | 5 | 135 | 2 | PF01290 | |
| Domain | Thymosin_b4 | 5.11e-04 | 5 | 135 | 2 | PD005116 | |
| Domain | THY | 5.11e-04 | 5 | 135 | 2 | SM00152 | |
| Domain | Beta-thymosin | 5.11e-04 | 5 | 135 | 2 | IPR001152 | |
| Domain | Znf_PHD | 5.18e-04 | 91 | 135 | 5 | IPR001965 | |
| Domain | IQ | 5.72e-04 | 93 | 135 | 5 | PS50096 | |
| Domain | ZF_PHD_2 | 6.30e-04 | 95 | 135 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 6.61e-04 | 96 | 135 | 5 | PS01359 | |
| Domain | PAP_assoc | 1.06e-03 | 7 | 135 | 2 | PF03828 | |
| Domain | PAP_assoc | 1.06e-03 | 7 | 135 | 2 | IPR002058 | |
| Domain | Chromodomain-like | 1.57e-03 | 32 | 135 | 3 | IPR016197 | |
| Domain | Chromo/shadow_dom | 1.72e-03 | 33 | 135 | 3 | IPR000953 | |
| Domain | CHROMO | 1.72e-03 | 33 | 135 | 3 | SM00298 | |
| Domain | IQ | 1.74e-03 | 71 | 135 | 4 | PF00612 | |
| Domain | Myosin_head_motor_dom | 2.59e-03 | 38 | 135 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.59e-03 | 38 | 135 | 3 | PS51456 | |
| Domain | Myosin_head | 2.59e-03 | 38 | 135 | 3 | PF00063 | |
| Domain | MYSc | 2.59e-03 | 38 | 135 | 3 | SM00242 | |
| Domain | Snf7_fam | 3.26e-03 | 12 | 135 | 2 | IPR005024 | |
| Domain | Snf7 | 3.26e-03 | 12 | 135 | 2 | PF03357 | |
| Domain | Rho_GTPase_activation_prot | 3.81e-03 | 88 | 135 | 4 | IPR008936 | |
| Domain | Znf_FYVE_PHD | 4.31e-03 | 147 | 135 | 5 | IPR011011 | |
| Domain | RasGAP | 4.46e-03 | 14 | 135 | 2 | SM00323 | |
| Domain | RasGAP_CS | 4.46e-03 | 14 | 135 | 2 | IPR023152 | |
| Domain | DnaJ | 5.04e-03 | 48 | 135 | 3 | PF00226 | |
| Domain | - | 5.12e-03 | 15 | 135 | 2 | 1.10.150.60 | |
| Domain | RasGAP | 5.12e-03 | 15 | 135 | 2 | PF00616 | |
| Domain | BRIGHT | 5.12e-03 | 15 | 135 | 2 | SM00501 | |
| Domain | ARID_dom | 5.12e-03 | 15 | 135 | 2 | IPR001606 | |
| Domain | ARID | 5.12e-03 | 15 | 135 | 2 | PS51011 | |
| Domain | RAS_GTPASE_ACTIV_1 | 5.12e-03 | 15 | 135 | 2 | PS00509 | |
| Domain | RAS_GTPASE_ACTIV_2 | 5.12e-03 | 15 | 135 | 2 | PS50018 | |
| Domain | ARID | 5.12e-03 | 15 | 135 | 2 | PF01388 | |
| Domain | DNAJ_1 | 5.34e-03 | 49 | 135 | 3 | PS00636 | |
| Domain | DNAJ_2 | 5.34e-03 | 49 | 135 | 3 | PS50076 | |
| Domain | DnaJ | 5.34e-03 | 49 | 135 | 3 | SM00271 | |
| Domain | - | 5.34e-03 | 49 | 135 | 3 | 1.10.287.110 | |
| Domain | DnaJ_domain | 5.97e-03 | 51 | 135 | 3 | IPR001623 | |
| Pubmed | CYLC1 UIMC1 MYH1 MYH4 MYH8 STIM2 TCERG1L PRELID1 FAM133A KDM5A ERC1 SYNE1 PSMA6 KRBA2 SRSF11 ZNF318 ZFC3H1 NEB PNISR TRDN LYST ERLIN1 TMSB4Y FAM133B DNAJC11 ITSN2 SAP30BP TENM1 EIF5B TMSB4X MPHOSPH8 DNAJC3 DYNC1I2 HDAC1 | 3.05e-17 | 1442 | 139 | 34 | 35575683 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UIMC1 FILIP1 DNAJC13 ARID4B KDM5A RBBP6 DLGAP5 KDM3B MCM3 ZNF318 REST PNISR NF1 FAM13A EIF5B RERE SF3B2 PCM1 DYNC1I2 IQCK SON | 5.18e-12 | 774 | 139 | 21 | 15302935 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | UIMC1 SETX ARID4B PHF20 KDM5A RBBP6 DLGAP5 SRSF11 ZNF318 REST ZFC3H1 POM121C PNISR SP110 NSD3 NOP58 YEATS4 CDC40 SUDS3 SAP30BP MPHOSPH8 NKTR SF3B2 HDAC1 SLC27A2 SON | 1.02e-11 | 1294 | 139 | 26 | 30804502 |
| Pubmed | UIMC1 PCYT1A VRK1 ZMYND11 MIS18BP1 RBBP6 PSMA6 KDM3B MCM3 CHD9 POLR3A NSD3 NOP58 NAMPT UBE2L3 SUDS3 CFDP1 EIF2S2 EIF5B MPHOSPH8 SF3B2 HDAC1 SON | 1.69e-11 | 1014 | 139 | 23 | 32416067 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | UIMC1 PCYT1A VRK1 ZMYND11 MIS18BP1 SETX ARID4B KDM5A PSMA6 DLGAP5 KDM3B CHD9 NSD3 NOP58 NFATC2IP CFDP1 MPHOSPH8 HDAC1 | 4.74e-11 | 608 | 139 | 18 | 36089195 |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | ZC3H15 MCM3 SRSF11 ZFC3H1 NOP58 SUDS3 SAP30BP EIF2S2 EIF5B SF3B2 HDAC1 | 6.35e-11 | 163 | 139 | 11 | 22113938 |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | VRK1 SWAP70 FAM133A RBBP6 PSMA6 MCM3 PNISR MTPAP SDAD1 FAM133B ITSN2 SAP30BP EIF5 CCT6B MPHOSPH8 NKTR PCM1 HDAC1 | 4.66e-10 | 701 | 139 | 18 | 30196744 |
| Pubmed | ZMYND11 TUT4 ARID4B KDM5A RBBP6 ERC1 ZC3H15 CHD9 ZNF318 POM121C SP110 MTPAP NSD3 ZNHIT6 YEATS4 CCNB3 SUDS3 SAP30BP RERE PCM1 HDAC1 SON | 6.85e-10 | 1116 | 139 | 22 | 31753913 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | UIMC1 RBBP6 ERC1 ZC3H15 PSMA6 DLGAP5 KDM3B IST1 ZNF318 POM121C SNX29 NAMPT SAP30BP CFDP1 EIF5 EIF5B SF3B2 SNX1 PCM1 SON | 1.09e-09 | 934 | 139 | 20 | 33916271 |
| Pubmed | UIMC1 SETX KDM5A RBBP6 ZC3H15 SYNE1 IST1 ZNF318 ZFC3H1 PNISR MTPAP SDAD1 ERLIN1 NSD3 FAM133B DNAJC11 ITSN2 SAP30BP EIF2S2 EIF5 EIF5B MPHOSPH8 PRR11 HDAC1 SON | 1.25e-09 | 1497 | 139 | 25 | 31527615 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | UIMC1 VRK1 SETX ARID4B RBBP6 ZC3H15 DLGAP5 MCM3 SRSF11 ZNF318 NSD3 NOP58 SAP30BP EIF2S2 EIF5 EIF5B MPHOSPH8 SF3B2 PCM1 SON | 1.56e-09 | 954 | 139 | 20 | 36373674 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | VRK1 DNAJC13 SETX KDM5A RBBP6 ZC3H15 SYNE1 MCM3 CHD9 SRSF11 UPF3A PNISR SDAD1 NSD3 NOP58 CDC40 EIF2S2 EIF5B MPHOSPH8 SF3B2 SON | 2.30e-09 | 1082 | 139 | 21 | 38697112 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | VRK1 KDM5A RBBP6 PSMA6 KDM3B MCM3 SRSF11 MTPAP ERLIN1 FAM133B NOP58 NAMPT CDC40 DNAJC11 SAP30BP EIF2S2 EIF5B NKTR QARS1 SF3B2 HDAC1 SON | 1.41e-08 | 1318 | 139 | 22 | 30463901 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DNAJC13 MIS18BP1 SETX ABCF3 PSMA6 DLGAP5 MCM3 MTPAP ERLIN1 POLR3A NOP58 NAMPT NF1 CDC40 EIF2S2 CCT6B EIF5B PRR11 QARS1 SF3B2 DYNC1I2 SON | 2.25e-08 | 1353 | 139 | 22 | 29467282 |
| Pubmed | SRSF11 PNISR POLR3A NOP58 NAMPT ZNHIT6 YEATS4 CDC40 CCT6B SF3B2 PCM1 | 3.85e-08 | 300 | 139 | 11 | 28561026 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | UIMC1 SWAP70 ERC1 PSMA6 PARP3 MCM3 ERLIN1 POLR3A TMSB4Y DNAJC11 AP3B2 EIF2S2 EIF5 QARS1 SF3B2 DYNC1I2 HDAC1 | 5.44e-08 | 847 | 139 | 17 | 35235311 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | SWAP70 ZC3H15 DLGAP5 ZNF318 CCDC88A EIF5 EIF5B SF3B2 SNX1 PCM1 | 9.08e-08 | 256 | 139 | 10 | 33397691 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | VRK1 DNAJC13 ABCF3 SWAP70 ZC3H15 PSMA6 KDM3B IST1 ERLIN1 NOP58 NAMPT SAP30BP CFDP1 EIF5 EIF5B QARS1 SF3B2 SNX1 DYNC1I2 HDAC1 SON | 1.26e-07 | 1367 | 139 | 21 | 32687490 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | DNAJC13 TUT4 ABCF3 SWAP70 KDM5A ERC1 ZC3H15 ZFC3H1 NOP58 EIF5 EIF5B PRR11 QARS1 DYNC1I2 SON | 2.33e-07 | 724 | 139 | 15 | 36232890 |
| Pubmed | PCYT1A DNAJC13 SETX SWAP70 RBBP6 ZC3H15 DLGAP5 KDM3B SRSF11 MTPAP ERLIN1 NSD3 MET EIF5 EIF5B QARS1 DNAJC3 SNX1 PCM1 HDAC1 | 2.44e-07 | 1297 | 139 | 20 | 33545068 | |
| Pubmed | 2.49e-07 | 4 | 139 | 3 | 19525971 | ||
| Pubmed | 2.49e-07 | 4 | 139 | 3 | 1985022 | ||
| Pubmed | SWAP70 RBBP6 ERC1 KDM3B MCM3 ZNF318 NSD3 NOP58 YEATS4 SAP30BP SNX1 PCM1 HDAC1 | 3.49e-07 | 549 | 139 | 13 | 38280479 | |
| Pubmed | SETX FAM133A KDM5A PSMA6 SRSF11 MTPAP SDAD1 ERLIN1 NOP58 NAMPT CDC40 SAP30BP C1D NKTR TRPM1 PRR11 QARS1 SF3B2 PCM1 SON | 5.84e-07 | 1371 | 139 | 20 | 36244648 | |
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 6.21e-07 | 5 | 139 | 3 | 3829126 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 6.21e-07 | 5 | 139 | 3 | 12919077 | |
| Pubmed | 6.21e-07 | 5 | 139 | 3 | 6196357 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RBBP6 ERC1 ZC3H15 MCM3 ZFC3H1 MTPAP SDAD1 ERLIN1 NSD3 NOP58 CDC40 DNAJC11 SAP30BP EIF2S2 EIF5 EIF5B QARS1 SF3B2 HDAC1 | 6.79e-07 | 1257 | 139 | 19 | 36526897 |
| Pubmed | Abnormal Mammary Development in 129:STAT1-Null Mice is Stroma-Dependent. | 9.09e-07 | 44 | 139 | 5 | 26075897 | |
| Pubmed | DAB2IP PCYT1A SETX RBBP6 ERC1 DLGAP5 MCM3 FAM13A NFATC2IP EIF5B PCM1 SON | 9.31e-07 | 503 | 139 | 12 | 16964243 | |
| Pubmed | RBBP6 KDM3B SRSF11 ZNF318 PNISR YEATS4 SAP30BP CFDP1 CCT6B QARS1 SF3B2 SON | 9.91e-07 | 506 | 139 | 12 | 30890647 | |
| Pubmed | 1.24e-06 | 6 | 139 | 3 | 1728586 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 1.24e-06 | 6 | 139 | 3 | 10077619 | |
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 1.24e-06 | 6 | 139 | 3 | 10588881 | |
| Pubmed | 1.27e-06 | 47 | 139 | 5 | 8812413 | ||
| Pubmed | 2.04e-06 | 23 | 139 | 4 | 9651585 | ||
| Pubmed | UIMC1 VRK1 MIS18BP1 ARID4B ERC1 ZC3H15 DLGAP5 NSD3 YEATS4 NFATC2IP MPHOSPH8 SNX1 PCM1 | 2.10e-06 | 645 | 139 | 13 | 25281560 | |
| Pubmed | 2.16e-06 | 7 | 139 | 3 | 35210422 | ||
| Pubmed | 2.16e-06 | 7 | 139 | 3 | 16819597 | ||
| Pubmed | Identification and characterization of three new components of the mSin3A corepressor complex. | 3.45e-06 | 8 | 139 | 3 | 12724404 | |
| Pubmed | 3.45e-06 | 8 | 139 | 3 | 3864153 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | VRK1 ZC3H15 SYNE1 PSMA6 MCM3 SDAD1 POLR3A NOP58 NAMPT NF1 CDC40 DNAJC11 EIF2S2 EIF5 EIF5B MPHOSPH8 QARS1 SF3B2 HDAC1 | 4.25e-06 | 1425 | 139 | 19 | 30948266 |
| Pubmed | 4.34e-06 | 60 | 139 | 5 | 20682791 | ||
| Pubmed | SETX ARID4B RBBP6 SYNE1 NEB POM121C PNISR NSD3 CCDC88A ITSN2 NKTR | 4.45e-06 | 486 | 139 | 11 | 20936779 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | TUT4 RBBP6 ZC3H15 SYNE1 SRSF11 PNISR MTPAP FAM133B NOP58 EIF2S2 EIF5 EIF5B SF3B2 SON | 4.73e-06 | 807 | 139 | 14 | 22681889 |
| Pubmed | DNAJC13 RBBP6 CFAP43 MTPAP SNX29 SDAD1 ERLIN1 NOP58 CCNB3 EIF2S2 EIF5B | 5.39e-06 | 496 | 139 | 11 | 31343991 | |
| Pubmed | Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131. | 5.57e-06 | 110 | 139 | 6 | 26841866 | |
| Pubmed | TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. | 7.34e-06 | 10 | 139 | 3 | 21490601 | |
| Pubmed | 7.34e-06 | 10 | 139 | 3 | 19506036 | ||
| Pubmed | A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells. | MYH8 RBBP6 SDAD1 POLR3A NOP58 ZNHIT6 CFDP1 EIF2S2 EIF5 EIF5B | 7.75e-06 | 419 | 139 | 10 | 28700943 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | VRK1 SETX ABCF3 ARID4B KDM5A MTPAP YEATS4 NFATC2IP SUDS3 CFDP1 EIF2S2 EIF5B QARS1 SF3B2 | 9.33e-06 | 857 | 139 | 14 | 25609649 |
| Pubmed | 1.01e-05 | 11 | 139 | 3 | 8136524 | ||
| Pubmed | 1.01e-05 | 11 | 139 | 3 | 25189618 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | DNAJC13 ARID4B RBBP6 ZFC3H1 MTPAP SDAD1 FAM133B NOP58 CDC40 EIF2S2 QARS1 HDAC1 SON | 1.20e-05 | 759 | 139 | 13 | 35915203 |
| Pubmed | MCM3 PNISR MTPAP POLR3A NOP58 NAMPT ZNHIT6 CDC40 EIF5B QARS1 | 1.46e-05 | 451 | 139 | 10 | 30033366 | |
| Pubmed | The joining of ribosomal subunits in eukaryotes requires eIF5B. | 1.59e-05 | 2 | 139 | 2 | 10659855 | |
| Pubmed | Function of Thymosin Beta-4 in Ethanol-Induced Microglial Activation. | 1.59e-05 | 2 | 139 | 2 | 27189760 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 34414534 | ||
| Pubmed | Friction-driven membrane scission by the human ESCRT-III proteins CHMP1B and IST1. | 1.59e-05 | 2 | 139 | 2 | 35858336 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 35932611 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 16010974 | ||
| Pubmed | Thymosin β4 Deficiency Exacerbates Renal and Cardiac Injury in Angiotensin-II-Induced Hypertension. | 1.59e-05 | 2 | 139 | 2 | 29632102 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 34183019 | ||
| Pubmed | Downregulation of thymosin beta4 in neural progenitor grafts promotes spinal cord regeneration. | 1.59e-05 | 2 | 139 | 2 | 19861493 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 19477918 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 30552633 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 27433712 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 26361868 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 18427126 | ||
| Pubmed | Growth and muscle defects in mice lacking adult myosin heavy chain genes. | 1.59e-05 | 2 | 139 | 2 | 9382868 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 11150240 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 33526986 | ||
| Pubmed | Eukaryotic translation initiation factor 5 functions as a GTPase-activating protein. | 1.59e-05 | 2 | 139 | 2 | 11092890 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 37371128 | ||
| Pubmed | Muscle injury-induced thymosin β4 acts as a chemoattractant for myoblasts. | 1.59e-05 | 2 | 139 | 2 | 20880960 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 26255251 | ||
| Pubmed | [Overexpression of thymosin beta4 in the cochlea of senescence-accelerated mouse]. | 1.59e-05 | 2 | 139 | 2 | 15813012 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 29487953 | ||
| Pubmed | Thymosin β4 is essential for adherens junction stability and epidermal planar cell polarity. | 1.59e-05 | 2 | 139 | 2 | 33310787 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 2351831 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 24613476 | ||
| Pubmed | Discovery of thymosin β4 as a human exerkine and growth factor. | 1.59e-05 | 2 | 139 | 2 | 34495765 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 34348450 | ||
| Pubmed | Thymosin β4 administration enhances fracture healing in mice. | 1.59e-05 | 2 | 139 | 2 | 25042765 | |
| Pubmed | Membrane constriction and thinning by sequential ESCRT-III polymerization. | 1.59e-05 | 2 | 139 | 2 | 32251413 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 21626305 | ||
| Pubmed | Five skeletal myosin heavy chain genes are organized as a multigene complex in the human genome. | 1.59e-05 | 2 | 139 | 2 | 8518795 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 38049080 | ||
| Pubmed | Trichinella spiralis infection induces angiogenic factor thymosin β4 expression. | 1.59e-05 | 2 | 139 | 2 | 21531510 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 8634336 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 26789270 | ||
| Pubmed | Expression of thymosin β4 in odontoblasts during mouse tooth development. | 1.59e-05 | 2 | 139 | 2 | 22344518 | |
| Pubmed | Thymosin beta 4 mRNA and peptide expression in phagocytic cells of different mouse tissues. | 1.59e-05 | 2 | 139 | 2 | 19631707 | |
| Pubmed | Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. | 1.59e-05 | 2 | 139 | 2 | 17676051 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 10805737 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 27130465 | ||
| Pubmed | Structure and membrane remodeling activity of ESCRT-III helical polymers. | 1.59e-05 | 2 | 139 | 2 | 26634441 | |
| Pubmed | Functional interaction of the cytoplasmic domain of triadin with the skeletal ryanodine receptor. | 1.59e-05 | 2 | 139 | 2 | 10212196 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 38520674 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 9395514 | ||
| Interaction | NUP43 interactions | MIS18BP1 SETX ARID4B KDM5A RBBP6 TTC14 CHD9 ZNF318 ZFC3H1 POM121C SDAD1 NSD3 NOP58 CCDC88A NFATC2IP CCT6B NKTR RERE SON | 6.12e-08 | 625 | 139 | 19 | int:NUP43 |
| Interaction | PHLPP1 interactions | SWAP70 ZC3H15 DLGAP5 SRSF11 ZNF318 NEB CCDC88A EIF5 EIF5B SF3B2 SNX1 PCM1 HDAC1 | 5.45e-07 | 333 | 139 | 13 | int:PHLPP1 |
| Interaction | SMC5 interactions | UIMC1 MYH1 MYH4 VRK1 SETX ARID4B RBBP6 ZC3H15 DLGAP5 MCM3 SRSF11 ZNF318 NSD3 NOP58 SAP30BP EIF2S2 EIF5 EIF5B MPHOSPH8 SF3B2 PCM1 SON | 1.36e-06 | 1000 | 139 | 22 | int:SMC5 |
| Interaction | MECP2 interactions | VRK1 DNAJC13 SETX KDM5A RBBP6 ZC3H15 SYNE1 MCM3 CHD9 SRSF11 UPF3A PNISR SDAD1 NSD3 NOP58 CDC40 EIF2S2 EIF5B MPHOSPH8 NKTR SF3B2 SNX1 HDAC1 SON | 7.47e-06 | 1287 | 139 | 24 | int:MECP2 |
| Interaction | LZTR1 interactions | 1.19e-05 | 111 | 139 | 7 | int:LZTR1 | |
| Interaction | NAA40 interactions | UIMC1 RBBP6 ERC1 ZC3H15 PSMA6 DLGAP5 KDM3B IST1 ZNF318 POM121C SNX29 NAMPT SAP30BP CFDP1 EIF5 EIF5B SF3B2 SNX1 PCM1 SON | 1.27e-05 | 978 | 139 | 20 | int:NAA40 |
| Interaction | H3C1 interactions | UIMC1 VRK1 ZMYND11 ARID4B PHF20 KDM5A SYNE1 DLGAP5 NEB SDAD1 NSD3 YEATS4 CCNB3 CFDP1 CCT6B MPHOSPH8 DNAJC3 SF3B2 HDAC1 | 1.40e-05 | 901 | 139 | 19 | int:H3C1 |
| Interaction | MXD1 interactions | 1.42e-05 | 45 | 139 | 5 | int:MXD1 | |
| Interaction | H3-3A interactions | UIMC1 PCYT1A VRK1 ZMYND11 ARID4B KDM5A PSMA6 KDM3B CHD9 NSD3 NFATC2IP DNAJC11 CFDP1 EIF5 MPHOSPH8 SF3B2 HDAC1 | 1.63e-05 | 749 | 139 | 17 | int:H3-3A |
| Interaction | ATP6V1B1 interactions | 1.98e-05 | 120 | 139 | 7 | int:ATP6V1B1 | |
| Interaction | KCNA3 interactions | STIM2 RBBP6 ERC1 ZC3H15 PSMA6 MCM3 CHD9 SDAD1 RYR1 ERLIN1 CCDC88A AP3B2 EIF5 EIF5B TRPM1 QARS1 SF3B2 HDAC1 | 3.14e-05 | 871 | 139 | 18 | int:KCNA3 |
| Interaction | CSNK2A1 interactions | ARID4B FAM133A ZC3H15 MCM3 SRSF11 ZFC3H1 LYST POLR3A NOP58 YEATS4 SUDS3 SAP30BP CFDP1 EIF2S2 EIF5 EIF5B NKTR SF3B2 HDAC1 | 3.17e-05 | 956 | 139 | 19 | int:CSNK2A1 |
| Interaction | SNRNP40 interactions | MIS18BP1 SETX RBBP6 TTC14 ZNF318 ZFC3H1 POM121C PNISR NSD3 NOP58 CDC40 NFATC2IP ITSN2 NKTR SON | 3.48e-05 | 637 | 139 | 15 | int:SNRNP40 |
| Interaction | DHX8 interactions | RBBP6 TTC14 SRSF11 ZNF318 ZFC3H1 PNISR CDC40 SAP30BP NKTR SON | 3.60e-05 | 292 | 139 | 10 | int:DHX8 |
| Interaction | H3C3 interactions | UIMC1 PCYT1A VRK1 MIS18BP1 SETX KDM5A DLGAP5 KDM3B NSD3 NOP58 NFATC2IP MPHOSPH8 HDAC1 | 3.95e-05 | 495 | 139 | 13 | int:H3C3 |
| Interaction | ATG16L1 interactions | VRK1 SWAP70 RBBP6 ERC1 PSMA6 MCM3 PNISR MTPAP SNX29 SDAD1 FAM133B GJB2 CCDC88A ITSN2 SAP30BP EIF5 CCT6B MPHOSPH8 NKTR PCM1 HDAC1 | 4.66e-05 | 1161 | 139 | 21 | int:ATG16L1 |
| Interaction | PNN interactions | ZMYND11 FAM133A RBBP6 SRSF11 PNISR TRDN CDC40 NKTR CNGB1 DYNC1I2 | 4.78e-05 | 302 | 139 | 10 | int:PNN |
| Interaction | SAP18 interactions | ZMYND11 ABCF3 ARID4B RBBP6 SRSF11 CDC40 SUDS3 NKTR HDAC1 SON | 5.19e-05 | 305 | 139 | 10 | int:SAP18 |
| Interaction | ABTB2 interactions | 7.15e-05 | 101 | 139 | 6 | int:ABTB2 | |
| Interaction | RSPH6A interactions | 8.56e-05 | 34 | 139 | 4 | int:RSPH6A | |
| Interaction | NR2C2 interactions | VRK1 KDM5A RBBP6 PSMA6 KDM3B MCM3 SRSF11 MTPAP ERLIN1 FAM133B NOP58 NAMPT CDC40 DNAJC11 ITSN2 SAP30BP EIF2S2 EIF5B NKTR QARS1 SF3B2 HDAC1 SON | 8.86e-05 | 1403 | 139 | 23 | int:NR2C2 |
| Interaction | H2BC21 interactions | CYLC1 UIMC1 VRK1 DNAJC13 ARID4B PARP3 MCM3 REST NEB NSD3 YEATS4 CFDP1 TENM1 MPHOSPH8 HDAC1 | 9.45e-05 | 696 | 139 | 15 | int:H2BC21 |
| Interaction | PRKAG2 interactions | 1.07e-04 | 68 | 139 | 5 | int:PRKAG2 | |
| Interaction | TERF2IP interactions | UIMC1 PCYT1A SETX RBBP6 KDM3B SRSF11 ZNF318 NSD3 TMSB4Y NFATC2IP SAP30BP CFDP1 SF3B2 | 1.19e-04 | 552 | 139 | 13 | int:TERF2IP |
| Interaction | CSNK2A2 interactions | TUT4 ARID4B FAM133A ZFC3H1 SP110 LYST SDAD1 POLR3A SUDS3 SAP30BP CFDP1 EIF5 NKTR SF3B2 HDAC1 | 1.33e-04 | 718 | 139 | 15 | int:CSNK2A2 |
| Interaction | HECTD1 interactions | DNAJC13 ARID4B FAM133A RBBP6 ZFC3H1 MTPAP SDAD1 POLR3A FAM133B NOP58 CDC40 UBE2L3 EIF2S2 CCT6B ATP6V1C2 QARS1 HDAC1 SON | 1.49e-04 | 984 | 139 | 18 | int:HECTD1 |
| Interaction | SUZ12 interactions | VRK1 SETX KDM5A SYNE1 REST ERLIN1 NOP58 NF1 CDC40 SUDS3 EIF2S2 SF3B2 HDAC1 SON | 1.49e-04 | 644 | 139 | 14 | int:SUZ12 |
| Interaction | HBP1 interactions | 2.12e-04 | 123 | 139 | 6 | int:HBP1 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 5.07e-06 | 51 | 89 | 5 | 870 | |
| GeneFamily | Myosin heavy chains | 5.03e-05 | 15 | 89 | 3 | 1098 | |
| GeneFamily | PHD finger proteins | 8.16e-05 | 90 | 89 | 5 | 88 | |
| GeneFamily | Charged multivesicular body proteins|ESCRT-III associated factors | 2.37e-04 | 5 | 89 | 2 | 1119 | |
| GeneFamily | Non-canonical poly(A) polymerases | 4.95e-04 | 7 | 89 | 2 | 1318 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 8.43e-04 | 9 | 89 | 2 | 1306 | |
| GeneFamily | Charged multivesicular body proteins|ESCRT-III associated factors | 1.28e-03 | 11 | 89 | 2 | 482 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 1.53e-03 | 12 | 89 | 2 | 1243 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 1.80e-03 | 49 | 89 | 3 | 584 | |
| GeneFamily | AT-rich interaction domain containing | 2.41e-03 | 15 | 89 | 2 | 418 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 3.11e-03 | 17 | 89 | 2 | 1291 | |
| GeneFamily | PWWP domain containing | 5.19e-03 | 22 | 89 | 2 | 1147 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 6.16e-03 | 24 | 89 | 2 | 485 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | VRK1 DNAJC13 TUT4 MIS18BP1 SETX ARID4B DLGAP5 SRSF11 UPF3A PNISR SDAD1 CCDC88A YEATS4 ABCA5 ITSN2 EIF2S2 EIF5B MPHOSPH8 NKTR TRPM1 DNAJC3 PCM1 SON | 7.21e-13 | 656 | 139 | 23 | M18979 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | STIM2 TUT4 MIS18BP1 SETX C6orf62 ARID4B PHF20 KDM5A RBBP6 SYNE1 TTC14 REST ZFC3H1 PNISR SP110 LYST CD2 CCDC88A NFATC2IP ITSN2 EIF5 TMSB4X MPHOSPH8 PCM1 SON | 2.85e-07 | 1492 | 139 | 25 | M40023 |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | VRK1 PRELID1 FAM133A ZC3H15 PSMA6 SRSF11 FAM133B NOP58 YEATS4 UBE2L3 SUDS3 CFDP1 EIF2S2 EIF5B C1D DNAJC3 SF3B2 SNX1 DYNC1I2 HDAC1 SON | 6.80e-07 | 1144 | 139 | 21 | MM3843 |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MATURE_ALPHA_BETA_T_CELL_AGEING | CHMP1B ZC3H15 PSMA6 KDM3B SP110 TMSB4Y CD2 CFDP1 SVBP EIF2S2 EIF5B C1D TMSB4X DNAJC3 SF3B2 | 9.56e-07 | 612 | 139 | 15 | MM3804 |
| Coexpression | GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN | 1.22e-06 | 199 | 139 | 9 | M7607 | |
| Coexpression | GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_DN | 1.28e-06 | 200 | 139 | 9 | M8403 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 3.04e-06 | 166 | 139 | 8 | M8129 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | VRK1 ZMYND11 DNAJC13 TUT4 SETX PHF20 SWAP70 KDM5A ERC1 DLGAP5 KDM3B CHD9 TDG PNISR NAMPT ITSN2 SON | 3.08e-06 | 856 | 139 | 17 | M4500 |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | MYH1 ZMYND11 RBBP6 ERC1 PARP3 POM121C SP110 RYR1 POLR3A GJB2 C1D DNAJC3 SF3B2 SON | 1.15e-05 | 659 | 139 | 14 | MM1040 |
| Coexpression | GSE27786_LIN_NEG_VS_BCELL_DN | 1.20e-05 | 200 | 139 | 8 | M4768 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_ERYTHROBLAST_AGEING | 1.33e-05 | 203 | 139 | 8 | MM3795 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | ZMYND11 SETX ARID4B ZC3H15 KDM3B UPF3A ZFC3H1 NF1 ITSN2 CHMP3 SON | 1.90e-05 | 429 | 139 | 11 | M29 |
| Coexpression | TBK1.DF_DN | 2.30e-05 | 286 | 139 | 9 | M2864 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | MYH1 ZMYND11 RBBP6 ERC1 PARP3 SP110 RYR1 POLR3A GJB2 C1D DNAJC3 SF3B2 SON | 2.52e-05 | 615 | 139 | 13 | M8673 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_DN | 2.61e-05 | 162 | 139 | 7 | M7002 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | ZMYND11 FAM133A CHMP1B SHOX2 SRSF11 MTPAP FAM133B NAMPT CFDP1 EIF2S2 EIF5B C1D | 2.89e-05 | 534 | 139 | 12 | MM1054 |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | MYH1 ZMYND11 RBBP6 ERC1 POM121C SP110 RYR1 POLR3A GJB2 C1D DNAJC3 SF3B2 SON | 4.45e-05 | 650 | 139 | 13 | MM1042 |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | VRK1 RBBP6 ZC3H15 PSMA6 DLGAP5 MCM3 SRSF11 TDG NF1 NFATC2IP EIF2S2 EIF5B C1D HDAC1 | 5.53e-05 | 761 | 139 | 14 | M11961 |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_UP | 5.86e-05 | 184 | 139 | 7 | M9988 | |
| Coexpression | OSMAN_BLADDER_CANCER_UP | 5.93e-05 | 402 | 139 | 10 | M5275 | |
| Coexpression | PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_3DY_DN | 7.25e-05 | 42 | 139 | 4 | M41055 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | ZMYND11 DNAJC13 SETX RBBP6 ZC3H15 KDM3B CHD9 TDG UPF3A REST PNISR SP110 ZNHIT6 FAM13A UBE2L3 EIF2S2 EIF5B PCM1 | 7.88e-05 | 1215 | 139 | 18 | M41122 |
| Coexpression | GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP | 9.59e-05 | 199 | 139 | 7 | M3328 | |
| Coexpression | GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_DN | 9.59e-05 | 199 | 139 | 7 | M6157 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_DN | 9.59e-05 | 199 | 139 | 7 | M5255 | |
| Coexpression | GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP | 9.59e-05 | 199 | 139 | 7 | M4460 | |
| Coexpression | GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN | 9.59e-05 | 199 | 139 | 7 | M5799 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_DN | 9.89e-05 | 200 | 139 | 7 | M3960 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_DN | 9.89e-05 | 200 | 139 | 7 | M3973 | |
| Coexpression | GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_DN | 9.89e-05 | 200 | 139 | 7 | M6966 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | MYH1 ZMYND11 RBBP6 ERC1 SP110 RYR1 POLR3A GJB2 C1D DNAJC3 SF3B2 SON | 1.03e-04 | 610 | 139 | 12 | M3854 |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 1.56e-04 | 20 | 139 | 3 | M1123 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 1.81e-04 | 21 | 139 | 3 | MM1102 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_FIBROBLAST_OF_LUNG_AGEING | 1.99e-04 | 224 | 139 | 7 | MM3767 | |
| Coexpression | GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN | 2.24e-04 | 161 | 139 | 6 | M6848 | |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP | PHF20 RBBP6 ZNF318 SP110 TMSB4Y NF1 NFATC2IP EIF5B ANKRD12 PCM1 | 2.31e-04 | 475 | 139 | 10 | M40979 |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_DN | FILIP1 MIS18BP1 PHF20 DLGAP5 TDG UPF3A REST MTPAP NSD3 NOP58 SUDS3 EIF5 NKTR DNAJC3 | 2.43e-04 | 877 | 139 | 14 | M2241 |
| Coexpression | GALE_APL_WITH_FLT3_MUTATED_UP | 2.75e-04 | 59 | 139 | 4 | M3845 | |
| Coexpression | GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP | 3.00e-04 | 170 | 139 | 6 | M5657 | |
| Coexpression | RUTELLA_RESPONSE_TO_HGF_DN | 3.03e-04 | 240 | 139 | 7 | M6413 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | PCYT1A MYH1 ZMYND11 RBBP6 ERC1 CHD9 RYR1 POLR3A C1D MPHOSPH8 DNAJC3 SF3B2 | 3.20e-04 | 690 | 139 | 12 | M12224 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | TUT4 MIS18BP1 SETX ARID4B PHF20 RBBP6 TTC14 CHD9 SRSF11 PNISR NOP58 CCDC88A UBE2L3 AP3B2 EIF2S2 EIF5 EIF5B C1D MPHOSPH8 TRPM1 PRR11 PCM1 IQCK SLC27A2 | 1.96e-05 | 1459 | 137 | 24 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | PCYT1A MYH8 DNAJC13 MIS18BP1 KDM5A MCM3 CHD9 SRSF11 ZNF318 PNISR NSD3 CCNB3 EIF2S2 MPHOSPH8 NKTR ANKRD12 | 4.17e-05 | 776 | 137 | 16 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | DAB2IP DNAJC13 TUT4 MIS18BP1 PHF20 TTC14 MCM3 CHD9 SRSF11 REST PNISR NSD3 NKTR ANKRD12 PLCL1 HAND2 | 6.07e-05 | 801 | 137 | 16 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.96e-05 | 281 | 137 | 9 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | MYH8 ARID4B TTC14 SHOX2 NEB PNISR GJB2 NAMPT CCDC88A DACH2 ABCA5 TENM1 C1D TRPM1 DYNC1I2 SON | 1.00e-04 | 836 | 137 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.40e-04 | 298 | 137 | 9 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | TUT4 MIS18BP1 SETX ARID4B ERC1 TTC14 CHD9 SP110 NSD3 NOP58 CCDC88A UBE2L3 EIF2S2 EIF5 EIF5B ANKRD12 PRR11 PCM1 DYNC1I2 IQCK | 1.56e-04 | 1252 | 137 | 20 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | TUT4 MIS18BP1 SETX ARID4B PHF20 RBBP6 TTC14 CHD9 SRSF11 PNISR NOP58 CCDC88A UBE2L3 EIF2S2 EIF5 EIF5B C1D MPHOSPH8 PRR11 PCM1 | 1.65e-04 | 1257 | 137 | 20 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.92e-04 | 311 | 137 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | UIMC1 TUT4 MIS18BP1 SETX ARID4B MAS1 TTC14 SHOX2 SRSF11 SNX29 CCDC88A ITSN2 EIF2S2 TRPM1 ACAP3 IQCK SLC27A2 | 1.93e-04 | 979 | 137 | 17 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | ARID4B KDM5A DLGAP5 CHD9 SRSF11 REST PNISR ZNHIT6 EIF2S2 C1D PCM1 IQCK SON | 2.22e-04 | 629 | 137 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | SETX ARID4B SRSF11 ZFC3H1 PNISR SP110 FAM133B ITSN2 NKTR ANKRD12 PCM1 SON | 1.74e-12 | 200 | 139 | 12 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | ARID4B SYNE1 TTC14 SRSF11 ZFC3H1 PNISR FAM133B TENM1 NKTR ANKRD12 PCM1 | 3.28e-11 | 197 | 139 | 11 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | KDM5A RBBP6 SRSF11 ZFC3H1 PNISR CCDC88A CFDP1 EIF5B MPHOSPH8 NKTR ANKRD12 | 3.28e-11 | 197 | 139 | 11 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | SYNE1 TTC14 SRSF11 ZFC3H1 PNISR FAM133B ABCA5 TENM1 NKTR ANKRD12 PCM1 | 3.66e-11 | 199 | 139 | 11 | f0b0097df0026496470a80d8cc9375ffd8389b00 |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | KDM5A SRSF11 PNISR IHO1 CCDC88A EIF5B NKTR ANKRD12 PRR11 SON | 5.23e-10 | 192 | 139 | 10 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e |
| ToppCell | Mild/Remission|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.40e-10 | 196 | 139 | 10 | 71603a3b7df40eb3f267345f55e44a812fea7926 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.72e-10 | 197 | 139 | 10 | ef2d1f56acd0be43e69bba7f73f6909ba87f1cb3 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 7.42e-10 | 199 | 139 | 10 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-09 | 178 | 139 | 9 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-08 | 194 | 139 | 9 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.35e-08 | 199 | 139 | 9 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.45e-08 | 173 | 139 | 8 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-07 | 187 | 139 | 8 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.60e-07 | 191 | 139 | 8 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.66e-07 | 192 | 139 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.73e-07 | 193 | 139 | 8 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.73e-07 | 193 | 139 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.87e-07 | 195 | 139 | 8 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.87e-07 | 195 | 139 | 8 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.94e-07 | 196 | 139 | 8 | a9157809122e6fc5783a291522f103bef30943e4 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 2.02e-07 | 197 | 139 | 8 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 2.10e-07 | 198 | 139 | 8 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.10e-07 | 198 | 139 | 8 | 33a3b279c9ff3b762e52d060dae062167ca2239b | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 2.18e-07 | 199 | 139 | 8 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 2.18e-07 | 199 | 139 | 8 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | Mild/Remission-B_naive-9|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.18e-07 | 199 | 139 | 8 | 0451b1536be3725a520bfdd2b3dff133bea812e8 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 2.18e-07 | 199 | 139 | 8 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.29e-07 | 148 | 139 | 7 | 4d43efee96a6493abd78e9ca41aab73db0c80626 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.13e-06 | 171 | 139 | 7 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-06 | 175 | 139 | 7 | 738b3d476ac494e2e79b70b3b83bc1b7ae8396bd | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.48e-06 | 178 | 139 | 7 | f94e306b9550f3d1b5de0bb806790c17823d439e | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-06 | 182 | 139 | 7 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-06 | 182 | 139 | 7 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 184 | 139 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Occipital|World / Primary Cells by Cluster | 2.37e-06 | 191 | 139 | 7 | 467d6164aee7745d610cab512616dc7b69d2d8bd | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Occipital-15|World / Primary Cells by Cluster | 2.37e-06 | 191 | 139 | 7 | 190fadf6d7c5ba34d83ad6e5fa008451660db9cf | |
| ToppCell | Mild/Remission-B_naive-11|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.37e-06 | 191 | 139 | 7 | ebb165096de301ba663703d1662d9413ea317867 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1-4|World / Primary Cells by Cluster | 2.54e-06 | 193 | 139 | 7 | 2eb6e4cff4fe3ce564c1581f6f7df4834895aaa9 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-06 | 195 | 139 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-06 | 195 | 139 | 7 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | 3'|World / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.81e-06 | 196 | 139 | 7 | 44007f0c14e0f0703f7ee715b8eababb4d80a8b5 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.00e-06 | 198 | 139 | 7 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.00e-06 | 198 | 139 | 7 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 3.00e-06 | 198 | 139 | 7 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.00e-06 | 198 | 139 | 7 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 3.10e-06 | 199 | 139 | 7 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.21e-06 | 200 | 139 | 7 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.23e-06 | 135 | 139 | 6 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 4.80e-06 | 138 | 139 | 6 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 8.04e-06 | 151 | 139 | 6 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.69e-06 | 156 | 139 | 6 | 7569cab30caafcb273e8ef0b73c9e1bf87076984 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.12e-05 | 160 | 139 | 6 | 0bfdaf979e6f128cba2928ce16bca4d3deff8ac9 | |
| ToppCell | normal-na-Lymphocytic_T-T4_reg-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.24e-05 | 163 | 139 | 6 | 43887e7687fc6367efac0c1f56a9534b06f47b7f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 165 | 139 | 6 | e2aebb2fe197151e019371b8960f76f0c2386f08 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 165 | 139 | 6 | b087771499aeb31cc4a338d2d0a9392a4ec1ac45 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 165 | 139 | 6 | d8f8b088fd28a6b9dbd6b51bcaee42000e963321 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.34e-05 | 97 | 139 | 5 | f3c3fb260954f594a9ab8e1ac9a01115767cbc7a | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.48e-05 | 168 | 139 | 6 | b94b1f37c92e019d01ecfa3b7cc6797b6e4a56ff | |
| ToppCell | Severe-B_naive-11|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.63e-05 | 171 | 139 | 6 | 7c2699f19ca38414447a286f7658f507882d57c2 | |
| ToppCell | droplet-Marrow-nan-24m-Hematologic-erythroid_progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 172 | 139 | 6 | 910ec7794ea4000db4ef1e2c34e08dbc0243df2c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-05 | 174 | 139 | 6 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-B_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.25e-05 | 181 | 139 | 6 | 477c572c5c1efceee49732cc9e8b1dad68a7e6e5 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-B_cell-B_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.25e-05 | 181 | 139 | 6 | 909280b44085d8e96fcd3cbcba6bff94badd41e8 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-05 | 181 | 139 | 6 | ce0e39114bf3bcbcce0fd4c0d70bedadd0853e1d | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 182 | 139 | 6 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 182 | 139 | 6 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 183 | 139 | 6 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 2.39e-05 | 183 | 139 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 183 | 139 | 6 | 3991830726d05cf19606d540de04093985b7bdeb | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 183 | 139 | 6 | cc844f54c7564bf432b179ca63bc7c4b9b8cfdd9 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 183 | 139 | 6 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 184 | 139 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.47e-05 | 184 | 139 | 6 | bd786db4dc4edae6d5cfc0b69901983dea19f729 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 184 | 139 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 184 | 139 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 2.54e-05 | 185 | 139 | 6 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 185 | 139 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 186 | 139 | 6 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-05 | 187 | 139 | 6 | 91c8e93bde0d1d1a4e324b0acf2afda00f4fb3bf | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-05 | 187 | 139 | 6 | 382db691eb0b3e089e816bed3d6699cc2d4e1bda | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.78e-05 | 188 | 139 | 6 | d8decd9b5967873ca8320c2f9f07365f163c777f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.87e-05 | 189 | 139 | 6 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-naive_B_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.04e-05 | 191 | 139 | 6 | a073d58154c801ec499fd969f42b7f1ee7f15d79 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 3.04e-05 | 191 | 139 | 6 | 3ae18bc4e3dff49b5d5958da8ebc3f747274b69c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.04e-05 | 191 | 139 | 6 | d9a6f61fcda4f5352488f7f55cb9b57aeacc717f | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.13e-05 | 192 | 139 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Mild/Remission-B_naive-11|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.13e-05 | 192 | 139 | 6 | c6f325cddce43b72f013b21dfffc9987fd68b6a7 | |
| ToppCell | control-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.22e-05 | 193 | 139 | 6 | 89d407a88b5956559a589425b89b3eb8dc78e1dd | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.22e-05 | 193 | 139 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.22e-05 | 193 | 139 | 6 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 3.22e-05 | 193 | 139 | 6 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 3.22e-05 | 193 | 139 | 6 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.32e-05 | 194 | 139 | 6 | d852aebf7a763b9a776c4570711f0c759f591910 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.42e-05 | 195 | 139 | 6 | 481989d2e5bd2582da3d86b0155c4d6615317067 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.42e-05 | 195 | 139 | 6 | 6108a27523d1b93a7fbe35cb95704a5ad9071e3c | |
| ToppCell | PBMC-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 3.42e-05 | 195 | 139 | 6 | 674355ca00314bde90ef7f6ddb83afe2d5323130 | |
| ToppCell | control-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.42e-05 | 195 | 139 | 6 | 66959ae839eb60a573da06bdd227090ebb5bb9ed | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-05 | 195 | 139 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-05 | 197 | 139 | 6 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-05 | 197 | 139 | 6 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.89e-05 | 49 | 98 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A | 1.75e-06 | 181 | 139 | 9 | 1791_DN | |
| Drug | Spermine | 2.37e-06 | 63 | 139 | 6 | ctd:D013096 | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 2.73e-06 | 191 | 139 | 9 | 4279_DN | |
| Drug | Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; PC3; HT_HG-U133A | 3.11e-06 | 194 | 139 | 9 | 4320_DN | |
| Drug | 34 C | 7.34e-06 | 21 | 139 | 4 | CID000002084 | |
| Drug | nocodazole | MYH1 MYH4 MYH8 VRK1 RBBP6 DLGAP5 CD2 GJB2 YEATS4 GBP4 CCNB3 PCM1 DYNC1I2 | 7.54e-06 | 477 | 139 | 13 | CID000004122 |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; HL60; HT_HG-U133A | 1.86e-05 | 185 | 139 | 8 | 1833_DN | |
| Drug | Kawain [500-64-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A | 2.25e-05 | 190 | 139 | 8 | 2299_DN | |
| Drug | Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 2.34e-05 | 191 | 139 | 8 | 2634_DN | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; PC3; HT_HG-U133A | 2.43e-05 | 192 | 139 | 8 | 4268_DN | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 2.61e-05 | 194 | 139 | 8 | 4312_DN | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.71e-05 | 195 | 139 | 8 | 1053_DN | |
| Drug | Pentoxifylline [6493-05-6]; Down 200; 14.4uM; HL60; HG-U133A | 2.81e-05 | 196 | 139 | 8 | 1444_DN | |
| Drug | Mebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; HL60; HG-U133A | 2.92e-05 | 197 | 139 | 8 | 1576_UP | |
| Drug | Betonicine [515-25-3]; Down 200; 25.2uM; MCF7; HT_HG-U133A | 2.92e-05 | 197 | 139 | 8 | 6063_DN | |
| Drug | torcetrapib | PCYT1A DNAJC13 SETX ARID4B RBBP6 ERC1 CHD9 CCDC88A NFATC2IP PCM1 | 4.93e-05 | 342 | 139 | 10 | ctd:C483909 |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.05e-05 | 10 | 133 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.05e-05 | 10 | 133 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.05e-05 | 10 | 133 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.05e-05 | 10 | 133 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.05e-05 | 10 | 133 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.05e-05 | 10 | 133 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.05e-05 | 10 | 133 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.05e-05 | 10 | 133 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 1.91e-05 | 12 | 133 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.91e-05 | 12 | 133 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 2.48e-05 | 13 | 133 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 3.92e-05 | 15 | 133 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Liposarcoma, Pleomorphic | 1.20e-04 | 4 | 133 | 2 | C0205825 | |
| Disease | arthrogryposis multiplex congenita (is_implicated_in) | 1.20e-04 | 4 | 133 | 2 | DOID:0080954 (is_implicated_in) | |
| Disease | pain | 2.71e-04 | 196 | 133 | 6 | EFO_0003843 | |
| Disease | liposarcoma | 2.99e-04 | 6 | 133 | 2 | C0023827 | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 2.99e-04 | 6 | 133 | 2 | C1854678 | |
| Disease | Liposarcoma, well differentiated | 2.99e-04 | 6 | 133 | 2 | C1370889 | |
| Disease | Liposarcoma, Dedifferentiated | 2.99e-04 | 6 | 133 | 2 | C0205824 | |
| Disease | blood pressure, chronic obstructive pulmonary disease | 4.04e-04 | 32 | 133 | 3 | EFO_0000341, EFO_0004325 | |
| Disease | suberic acid measurement | 4.17e-04 | 7 | 133 | 2 | EFO_0010534 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 4.79e-04 | 80 | 133 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | beverage consumption measurement | 5.50e-04 | 83 | 133 | 4 | EFO_0010088 | |
| Disease | alopecia areata (is_marker_for) | 8.86e-04 | 10 | 133 | 2 | DOID:986 (is_marker_for) | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 1.03e-03 | 169 | 133 | 5 | DOID:3908 (is_marker_for) | |
| Disease | alpha fetoprotein measurement | 1.11e-03 | 100 | 133 | 4 | EFO_0010583 | |
| Disease | cardiovascular disease | 1.13e-03 | 457 | 133 | 8 | EFO_0000319 | |
| Disease | pulmonary function measurement, smoking behaviour measurement, FEV/FEC ratio | 1.26e-03 | 47 | 133 | 3 | EFO_0003892, EFO_0004713, EFO_0005671 | |
| Disease | Congenital myopathy (disorder) | 1.29e-03 | 12 | 133 | 2 | C0270960 | |
| Disease | myopathy (implicated_via_orthology) | 1.34e-03 | 48 | 133 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | pulmonary function measurement, FEV/FEC ratio | 1.78e-03 | 53 | 133 | 3 | EFO_0003892, EFO_0004713 | |
| Disease | high grade glioma (biomarker_via_orthology) | 2.04e-03 | 15 | 133 | 2 | DOID:3070 (biomarker_via_orthology) | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 2.32e-03 | 16 | 133 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | ischemia (biomarker_via_orthology) | 2.94e-03 | 18 | 133 | 2 | DOID:326 (biomarker_via_orthology) | |
| Disease | Tourette syndrome, schizophrenia | 2.94e-03 | 18 | 133 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | response to methotrexate, neurotoxicity | 3.28e-03 | 19 | 133 | 2 | EFO_0011057, GO_0031427 | |
| Disease | periodontitis (biomarker_via_orthology) | 4.00e-03 | 21 | 133 | 2 | DOID:824 (biomarker_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 4.09e-03 | 71 | 133 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 4.24e-03 | 447 | 133 | 7 | C3714756 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SKEKQEKITDTFKVK | 91 | Q13569 | |
| EKITDTFKVKRKVDR | 96 | Q13569 | |
| KSKEAFIEAVERKKK | 21 | Q9BXU7 | |
| DILDKIKSKAKETKR | 801 | Q9BXU7 | |
| DKKDFLLSRKVKKVA | 1301 | Q8WWZ7 | |
| TKKRKDVKKDTTDKS | 801 | Q4LE39 | |
| KSRKEKSTEKGEELK | 411 | Q5RHP9 | |
| IKKEVNLFSKKRKEI | 796 | Q8NDM7 | |
| EEKVKRSVKDAAKKG | 41 | Q9Y3E7 | |
| KEKKKKSALFEVSEV | 41 | Q9GZU0 | |
| KKIAQFRKEKETFKE | 66 | P06729 | |
| KQKVVEKEAETERKK | 201 | O75477 | |
| KAKQEKRSEKDTLKT | 131 | Q9NUQ8 | |
| RKFKETKKQFDKVRE | 116 | Q96P50 | |
| VKLFKFSREKKAAKT | 281 | P35368 | |
| EKKRKFIKGEIKSEF | 101 | P29033 | |
| NFKEERDKIKKESEK | 746 | Q6UB98 | |
| KEKKTKRKLQEALEF | 521 | Q96NX9 | |
| EKKKAEKKFIDIAAA | 431 | Q13217 | |
| KKAKKDKDLTADRTI | 481 | Q86XH1 | |
| FKEEKVSLKKKCTTQ | 526 | Q8WWL7 | |
| VIKDKSEFKTKLSKN | 131 | Q9BYT9 | |
| EQSEEDGKRKTKKKV | 736 | Q13367 | |
| KLFRTEQVFEKSKKK | 651 | Q09MP3 | |
| KKKTQEEVAALKREK | 951 | Q8IUD2 | |
| KDKDTLKAEEKKRET | 741 | Q9NZM3 | |
| AKKEKCFERKRTKFI | 151 | Q8N0W5 | |
| KEQIGFTKERKKKFE | 121 | O60890 | |
| FTKERKKKFEKDGER | 126 | O60890 | |
| AKKDFEKKFREKTKN | 121 | Q9Y6F1 | |
| KELSRSAKKCDKEEK | 16 | Q7LBR1 | |
| KIDAAVSDKEKKKTY | 386 | P09238 | |
| VTVHLYRETDKKKKK | 271 | Q5VWQ8 | |
| VAEEEETSVKKKKKR | 476 | Q9Y2X3 | |
| KNEKSVKAEKRDVSK | 461 | Q13127 | |
| DEESSTKKKKKVESK | 536 | Q13127 | |
| KFVNDKSRKSEKVKV | 471 | Q9NVH1 | |
| KKSKDETEKEKDVRS | 161 | Q8N9E0 | |
| SETEKEIKRKAEVKK | 776 | Q6P0N0 | |
| SKKKRFKESLKVVLT | 286 | P04201 | |
| NFKKAKRVKTEDEKE | 436 | Q13547 | |
| EKKKRAKDKCDSETL | 121 | Q8IYA8 | |
| GKAEEKTKVKREIVK | 281 | Q9NQ38 | |
| ERKKKETDQKKEAVA | 31 | Q13409 | |
| RVKEITDKKKAGKLD | 96 | Q13901 | |
| SKLSKIEFEKRQIKK | 601 | Q3V6T2 | |
| KTKDELAKSEAKRKE | 861 | P13535 | |
| EKNKKKFGVESDKRV | 46 | Q15154 | |
| KKVKDVEEKSKEFVQ | 251 | P49585 | |
| RNKEVKSAFKKVVEK | 291 | Q8NH48 | |
| KSAFKKVVEKAKLSV | 296 | Q8NH48 | |
| KKARQEIKKKSSDTL | 131 | O43312 | |
| KKDIKKDARKDTEST | 506 | P35663 | |
| AVKSSKGKKKRESIE | 266 | Q7LBC6 | |
| EKIFVKCEIKSKTSK | 481 | P11150 | |
| KKLVDTIEKKKGDFV | 396 | Q96PP9 | |
| EKTKEELAKTEAKRK | 861 | P12882 | |
| FTKKKSNKFAIETVK | 541 | Q9NVV4 | |
| KKKIRKFEDRFEEEK | 676 | O94988 | |
| KKKKTKKIFDIDEAE | 81 | P20042 | |
| VKESTEKKREKKVLD | 1576 | P29375 | |
| KDVKSEKLTTKEEKA | 1116 | Q7Z6E9 | |
| KRKRKTEEKGVDKDF | 1146 | Q7Z6E9 | |
| SALKEKKKKRTVEEE | 291 | A8CG34 | |
| AFKAEIKKTDVKEEK | 166 | P61296 | |
| IAKIKKFSKTRSKDI | 281 | P25205 | |
| VKKHVREKEFTVKIK | 2336 | Q3L8U1 | |
| KPKETEKVKITKVFD | 156 | Q9UEE9 | |
| EKASKKYVSKELAKE | 356 | P55010 | |
| AKKKKSSEEREKATE | 206 | Q5BKY9 | |
| KVIDKKRAKKDTYVT | 91 | P57058 | |
| KDFLKKEIVDDTKVK | 186 | Q9NWK9 | |
| QTSEKKVSDKEKKVV | 181 | Q15398 | |
| KRKTFSLVKEKKAAR | 351 | P11229 | |
| EKKHSFLKKAKEVSE | 276 | Q494V2 | |
| KSKEKIGKEFKRIVQ | 141 | P49913 | |
| KAAKEVEKFAKEKVD | 706 | O75165 | |
| EAESTTEKGKKIKKR | 1486 | Q99698 | |
| EKKKTELAQKARKEI | 26 | P53990 | |
| DQKFKKVKECSSELK | 641 | Q5JRC9 | |
| KSFFVKKKEKEAEDT | 171 | Q9ULL0 | |
| EEKTEKKKTRKISQS | 2831 | P21817 | |
| FQTIKEVKEAKEKGK | 136 | Q6ZNG9 | |
| KRISEAKEELKESKK | 201 | Q99549 | |
| EKNKEKKFKEFVRVK | 526 | Q9BVI0 | |
| TEKRKKRSTKKEVFN | 301 | P08581 | |
| EKKFKVAKARLEETD | 186 | P47897 | |
| KVIEDFKTKAKENKF | 231 | Q8NEY4 | |
| KVKESVSRVEKAKQK | 11 | Q8N300 | |
| LKNSFKADKEAKRKE | 361 | Q8IWZ5 | |
| KTAEEKEKLVKAERK | 251 | Q92526 | |
| ERKKKKKVTNIISFD | 256 | Q8TEQ0 | |
| HKEKEKFTKAKELIS | 4946 | Q8NF91 | |
| KLKAITSKSKEDRQK | 281 | Q7Z7B0 | |
| LATKSIKDVFEKKRK | 176 | P30414 | |
| AKAQTEKKKLRDVFK | 441 | O14975 | |
| KETDKQKKIAEKEVR | 266 | Q9H1J1 | |
| ASFKIKTVAQKKAEK | 221 | O60841 | |
| KTLVETAKEAKEKAK | 176 | Q9Y255 | |
| TVFETGQKKTEKRKK | 166 | O60508 | |
| KFIKGVSEKIKKTRD | 971 | O14802 | |
| TDAKLRKKFFEKKFT | 216 | Q9H0A6 | |
| SKRKTKVQKDEICAK | 776 | Q7Z333 | |
| AFVSKSFDQKVKEKK | 6 | O60902 | |
| VAFLTKEDELKKKEK | 156 | Q96M53 | |
| SIKKAIKDKTAFLKV | 381 | Q9BXF9 | |
| KVSDKSEKKVFQKGR | 381 | Q9UKZ4 | |
| FATKIRADKIEKVKD | 331 | Q9BXB7 | |
| EKTKEELAKTEAKRK | 861 | Q9Y623 | |
| EKKTENSKLRKVKYE | 41 | P43490 | |
| AETVKKSAKKVKEEA | 626 | Q9P2R6 | |
| KTDRKEFVRKKTKTN | 621 | Q9NVU7 | |
| KEKKKEKDICSSSKR | 426 | Q9HB58 | |
| TKDKEEKKKTEFLDL | 181 | Q8NCF5 | |
| LVKLFKERTEKVKEK | 571 | Q14028 | |
| VKTRIKEEYKEKKSK | 501 | Q5VWI1 | |
| KQTESTSFLEKKVKK | 171 | P60900 | |
| KEAKIRLKFKEIQKS | 276 | Q15111 | |
| EAFKLTDDVKKEKEK | 391 | Q13435 | |
| KEVIRFEKEKSKDFK | 476 | Q13596 | |
| STSKTRDKKKEDKEK | 306 | Q05519 | |
| KDEAEKIKKKRSTVF | 381 | Q9P246 | |
| EKFDKSKLKKTETQE | 11 | O14604 | |
| LTFKEKVTSLKFKEK | 466 | P21359 | |
| EKEEKQKTKKIETSA | 441 | Q96N46 | |
| LEKAKKERTKIEFVT | 211 | Q9UHR5 | |
| AKKSVASKTEVKKTR | 406 | Q9BZ95 | |
| AKTITKKRKKEIEES | 351 | Q99986 | |
| TAEEKKVKKEKASTE | 1586 | Q7Z4N2 | |
| EKEDIKKKSEKETAI | 331 | Q13061 | |
| VKEKCKEEFVEEIKK | 531 | Q15326 | |
| RKEKQKREEKDFKFS | 691 | Q8TF01 | |
| VKEAKAKAKKESVDY | 256 | Q6R2W3 | |
| DKTFEISASDKKKKQ | 281 | Q9UH65 | |
| EQKKKEKIIEDKTFG | 16 | Q8WU90 | |
| EVKTREKLEAAKKKT | 176 | O95619 | |
| EKKAAVKEFEDKKVE | 131 | Q9H7L9 | |
| NKSTVDFKKREKGKI | 716 | Q5TAX3 | |
| LKAKAERLFKKKEAS | 11 | Q96HE9 | |
| KKKESVRNAEAKITK | 856 | O60293 | |
| KAKAVKEVKEDDKVS | 1216 | Q5VUA4 | |
| KKVKEVSESRNLEKK | 6 | Q96RL1 | |
| EIFVKVKDTHEKSKK | 1791 | P18583 | |
| KDRKKFCKNAEEFTK | 131 | P68036 | |
| EKFDKSKLKKTETQE | 11 | P62328 | |
| EKSKAKKFDIKVDAI | 566 | P20929 |